The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zirtek 10 mg film-coated tablets

UCB (Pharma) Ireland LimitedPA0891/008/002

Main Information

Trade NameZirtek 10 mg film-coated tablets
Active SubstancesCetirizine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderUCB (Pharma) Ireland Limited
Licence NumberPA0891/008/002

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine


License statusAuthorised
Licence Issued08/08/1988
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceRetail sale through pharmacies only in pack sizes not exceeding 7 tablets. As a prescription only item in pack sizes exceeding 7 tablets. Promotion: To the professions for pack sizes exceeding 7 tablets.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0088-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back